Double-blind, Randomized, Placebo-controlled Study on Efficacy, Safety and Tolerability of Ancrod in Patients With Sudden Sensorineural Hearing Loss (SSHL)
Phase of Trial: Phase I/II
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Ancrod (Primary) ; Ancrod (Primary)
- Indications Sensorineural hearing loss; Sudden hearing loss
- Focus Therapeutic Use
- Sponsors Nordmark Arzneimittel
- 27 Dec 2017 This trial has been Discontinued in Czech Republic, according to European Clinical Trials Database.
- 28 Sep 2017 Status changed from active, no longer recruiting to recruiting.
- 15 Jun 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.